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1. Introduction 
Loa loa encephalitis is becoming an important public health problem, as it impedes the use of 
some important drugs (ivermectin and DEC) for mass control of filarial disease in parts of 
West Africa where onchocerciasis is endemic. Loa encephalitis may occur either 
spontaneously or following chemotherapy targeting Loa loa. Although Loa loa is restricted to 
the West African rain forest block, imported cases are described throughout the world, due 
to intense economic, cultural and touristic population exchanges. The most common clinical 
features of loiaisis are swelling angioedema (calabar oedema) and ocular passage of the 
adult worm under the conjunctiva (eye worm). Loa loa disease may be particularly severe in 
expatriates (Nutman et al., 1986). Loa loa may cause a localized or systemic disease with 
involvement of deep organs including the kidney and heart. Only one-third of infected 
individuals have microfilariae in peripheral blood, leading to an underestimation of the 
prevalence of this infection. Most expatriates with loiasis have the adult worm but are 
amicrofilaremic (Churchill et al., 1996). The heterogeneous clinical expression of loisais 
encephalopathy calls for greater awareness among scientist and medical practitioners 
worldwide. 
2. The pathogen: Loa loa 
Loa loa is a filarial worm restricted to West Africa (Figure 1), from Guinea in the north 
through Benin to Uganda in the East, Gabon, Cameroun and Nigeria in the west, and 
Angola in the South. Parts of Cameroun, Gabon, Nigeria, Congo Brazzaville and Congo 
Kinshasa (DRC) are hyperendemic. Common clinical signs include eye worm and calabar 
swelling. Loa loa adults produce microfilariae that are released into the peripheral blood. 
They reach their maximal concentration in peripheral blood during daytime (diurnal 
periodicity). This larval stage of Loa loa is the likely etiologic agent of encephalitis during 
loiasis. The parasite was first described in 1770 (Mongin, 1770) in the eye of a servant in the 
island of St Domingue.  Only few autochtonous case of loaisis has been reported outside of 
Africa, in India (Barua et al., 2005; Kethan, 2007), although Loa loa can develop successfully 
in Chrysops atlanticus, which is widespread in Louisiana and Mississippi (Orihel & Lowrie, 
1975). Loa loa is thought to infect 13 million individuals living in endemic zones (Fain, 1978), 
as well as individuals visiting these areas (Varhaug,2005; Carbonez et al.,2002; Hee-Yoon et 
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al., 2008). However, this prevalence is based on the detection of microfilariae in blood and 
may therefore be an under-estimation, as about one-third of subjects are amicrofilaremic 
(Dupont et al., 1988). The adult worm can survive for up to 15 years in its human host.  
 
 
 
 
 
 
Fig. 1. Distribution of Loa loa 
The life cycle of Loa loa (Figure 2) starts when a female fly of the genus Chrysops (C. silacea, 
dimidiata or distinctipennis) bites an individual harboring L. loa microfilariae. The 
microfilariae reach the stomach of the fly and migrate to the fat body after several mutations 
to stage L3 (infective larvae). These migrate to the proboscis and are deposited in the host’s 
skin during the next blood meal. Once in the skin, the infective stages moult and reach the 
adult stage about a year later. The adult remains under the skin but can migrate to different 
parts of the body, including the ocular conjunctiva (hence the name ‘eye worm’). 
Microfilariae have a diurnal periodicity, being found in peripheral blood from about 5 am to 
7 pm, with peak from 9 am to 5 pm (Kershaw, 1950). The existence of an animal reservoir is 
a possibility (Fain., 1981), as about 10% of blood meals of C. silacea and C. dimidiate (Gouteux 
et al., 1989) from hippopotami, rodents, wild ruminants and monitor lizards contain L. loa 
microfilaria, and human L. loa isolates have been successfully maintained in drills (Duke, 
1957), baboons, and patas (Orihel & Moore., 1975), rhesus (Grieve et al., 1985), and mandrill 
monkeys (Pinder et al., 1994).  
www.intechopen.com
 
Encephalitis Due to Loa loa 343 
 
 
 
Fig. 2. Life cycle of Loa loa 
3. The vectors  
Chrysops dimidiata and C. silacea (Figure 3) (family Tabanidae) live in the canopy, and are 
particularly attracted by smoke and blue tissue. They lay eggs on mud or leaves 
overhanging water, and the larvae develop in detritus, taking a year before they pupate, 
with probably seven moults. The pupa is partially buried and the adult emerges after 1-3 
weeks. Chrysops is a good intermediate host or vector for Loa loa, and it is not unusual to 
find more than one hundred infective larvae in one fly. For vector control, William (1963) 
used water emulsions containing various concentrations of DDT, dieldrin, aldrin or gamma-
BHC, and found that Tabanus larvae were more susceptible than Chrysops larvae to all the 
insecticides tested. Dieldrin emulsion can keep breeding sites free of tabanid larvae for at 
least eight months (Crewe & Williams, 1964), and has been proposed for the control of 
chrysops larvae. However, vector control is difficult due to the scale and remote location of 
breeding sites. 
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Fig. 3. Chrysop silacea, vector of Loa loa 
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4. Diagnosis of loaisis 
4.1 Clinical diagnosis 
Calabar swelling commonly appears on the arm, elbow, face, or chest, and is often 
accompanied by localized pruritus and discomfort. Another diagnostic sign is ocular 
passage (Figure 4) of the adult worm (eye worm). These two signs are the most frequent and 
specific among autochtones and visitors. However, eye worm is more frequent in 
autochtones than in visitors, while calabar swelling is more common among visitors (82%) 
(Churchill et al., 1996). Visitors may developed a syndrome of immunological hyper-
responsiveness (Nutman et al., 1986) characterized by high titers of antifilarial antibodies, 
elevated IgE levels (Klion et al., 1991), hypereosinophilia, frequent pruritus around the 
angiodema, and complications such as endomyocardial fibrosis, renal disease, lymphoma 
(Gerd et al., 1996), and subcutaneous nodules. Calabar swelling and eye worm may appear 
alone or simultaneously. Retinal hemorrhage can occur in case of high microfilaremia 
(Toussaint & Danis 1965), especially after treatment with DEC or ivermectin. Examination of 
the fundus is therefore necessary, even in the absence of antifilarial treatment. Onset of 
calabar swelling and eye worm may be followed by cardiac (Andi et al., 1981), renal (Pilay et 
al., 1973; Bariety et al., 1967) or neurological disorders. Non specific symptoms include 
pruritus, fever, urticaria, rash, myalgia and arthralgia. 
 
 
 
Fig. 4. Ocular passage of Loa loa adult worm 
4.2 Biological diagnosis 
Direct specific diagnosis  
Direct specific diagnosis is based on detection of Loa loa microfilaria in peripheral blood or 
of the migrating adult worm. In wet films of blood samples taken around noon, Loa loa 
microfilaria are highly mobile, with a snake-like movement among red blood cells, 
enveloped in a translucid membrane (sheath). Body size is 231-300 µm by 5-7 µm. A 
concentration technique on fresh blood can be used: 1 ml of blood is diluted 10X in PBS 
(Akue et al., 1996), then red cells are lyzed with 2% saponin and the solution is centrifuge at 
2000 rpm for 10 minutes. The pellet is smeared on a slide and examined under a microscope. 
Microfilariae appear as described above. Microfilariae can also be stained with Giemsa in a 
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thick blood film, allowing Loa loa to be distinguished from other filariae by their size (253-
300 um long), their unstained sheath, and the presence of several nuclei inside the body, 
reaching the tail but not the cephalic extremity. Direct examination of cerebrospinal fluid 
(CSF) after centrifugation may be positive for microfilariae in case of neurological signs. The 
migrating adult worm is most readily detected during its ocular passage. The adult is 2-7 cm 
long, the female being longer than the male. 
 
 
 
 
 
 
 
Fig. 5. Stained Loa loa microfilaria 
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Fig. 6. Amplification of  Loa loa 15 kDa gene by PCR for diagnosis  
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Indirect (presumptive) diagnosis 
Indirect diagnosis is based on hypereosinophilia (25%) in general among non indigenous 
population from endemic zone, and elevated total IgE. As most infected people are 
amicrofilaremic, indirect methods based on antibody or gene detection are valuable.  One of 
the first such methods was the immunofluorescent antibody test (IFAT) using fixed 
microfilaria. Others include ELISA detection of specific IgG4 against a crude extract of Loa 
loa worm, a method that appears to be specific and sensitive for both microfilaremic and 
amicrofilaremic forms (Akue et al., 1994). Its sensitivity and specificity (relative to 
Mansonnella perstans) are reported to be better than 90% for parasitologically proven loiasis 
in a co-endemic area. However, crude extracts are in limited supply. A luciferase 
immunoprecipitation system (LIPS) based on detection of IgG to Loa loa recombinant 
antigen L1SXP-1 has been recently developed and shows high specificity but limited 
sensitivity. A rapid LIPS format improves the specificity by limiting cross-reactivity with O. 
volvulus (Burbelo et al., 2008). The same L1XP-1 antigen was used to develop an ELISA 
method for the detection of specific IgG4 antibodies, but sensitivity was poor (56%) (Klion et 
al., 2003). Molecular diagnosis may consist of detecting the ladder R3 gene (Ajuh et al., 1995) 
of Loa loa in DNA extracted from whole blood (Touré et al., 1997). However, although highly 
specific, the test is impractical in rural areas and non specialized laboratories.  In general, 
these methods, although specific, are not sensitive enough to detect all cases of loiasis and 
are not available at many points of care.  
5. Treatment and prophylaxis of uncomplicated loaisis 
The treatment of loiasis is based on two major microfilaricides, namely ivermectin 
(Mectizan® or Stromectol®) and diethylcarbamazine (DEC or Notezine®). With ivermectin, 
a single dose of 200 µg/kg is sufficient. DEC treatment starts with one-quarter of a tablet 
(one tablet = 100 mg), then the dose is doubled every day until the maximum dose of 400 
mg/day is reached. These treatments must be preceded by precise counting of microfilariae 
in the patient’s blood. If the count is higher than 8000 mf/ml, DEC will be administered at a 
dose of 8 mg/kg for 21 days under hospital supervision. This treatment is usually combined 
with antihistamine and corticosteroid therapy during the first week. Proposed 
chemoprophylaxis includes the use of repellents, and weekly intake of one tablet of DEC 
(100 mg). Plasmapheresis may be envisaged in case of very high microfilaremia (Muylle et 
al., 1983; Abel et al., 1986). 
6. Encephalopathy in loiasis: clinical features   
Loiasis encephalitis is usually a consequence of treatment with dimethyl carbamizine citrate 
(DEC) or ivermectin (Mectizan), although it may also occur spontaneously. 
6.1 Encephalopathy following treatment 
The symptoms occur gradually, staring 2 days after ivermectin treatment, or after 24-36 
hours of DEC treatment. The patient’s condition generally becomes serious after 3 to 5 days. 
The most common manifestations are vertigo, loss of balance, speaking difficulties, 
arthralgia, abdominal pain, diarrhea, fever, vomiting, diffuse hypertonia, loss of 
osteotendinous reflexes, no response to pain, conjunctival or retinal hemorrhage, pruritus, 
neurological disorders with altered consciousness (obnubilation), renal impairment, coma 
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and death after a few days. Laboratory tests show numerous Loa loa microfilaria in 
peripheral blood, cerebrospinal fluid (CSF) and urine. Loaisis encephalopathy is classified 
according to the neurological manifestations, their time of onset, and biological findings, in 
three categories: definite, probable and possible (Scientific working Group on SEA, 2003). 
6.1.1 Definite Loa loa encephalopathy: microscopic examination of brain tissue obtained by 
autopsy or needle biopsy is consistent with Loa loa encephalopathy (vasculopathy with 
evidence of Loa loa microfilariae), and onset of central nervous system (CNS) disorders 
within 7 days of treatment with mectizan, progressing to coma without remission. 
6.1.2 Probable Loa loa encephalopathy: encephalopathy (without seizures, usually febrile) in 
a previously healthy person with no other cause of encephalopathy, and onset of CNS 
symptoms and signs within 7 days of treatment with metizan, progressing to coma without 
remission; and >10 000 mf/ml of peripheral blood pre-treatment, or >1000 mf/ml within 6 
months post-treatment, or >2700 mf/ml within 6 months of treatment, and /or L. loa 
microfilariae in CSF. 
6.1.3 Possible L. loa encephalopathy: encephalopathy (without seizures, usually febrile) in a 
previously healthy person with no other underlying cause of encephalopathy, and onset of 
CNS symptoms and signs within 7 days of treatment with mectizan, progressing to coma 
without remission, and semi-quantitatively or qualitatively positive (+, ++ or +++) for L. loa 
microfilariae in peripheral blood or CSF. 
6.2 Spontaneous encephalopathy 
Spontaneous cases are rare but may be under-estimated. A number of apparently cases of 
spontaneous encephalitis have been been reported ( Bonet ,1943; Gallais et al., 1954; Carayon 
et al., 1959; Same Ekobo et al., 1981; Tuna Lukiana et al., 2006). In some case described by 
Kivit (1952), patients might have taken antifilarial drugs. The symptomatology is variable 
and may start with calabar swelling accompanied by itching, asthenia, facial edema, 
abdominal pain, diarrhea, violent headache, renal failure, hemiplegia or double hemiplegia, 
with mental disorders, functional impairment, altered consciousness including coma, 
usually terminating in sudden death. The process can last between 1 and 3 months, with 
hyperthermia in some case. The electroencephalogram may be abnormal (Bogaert et al., 
1955). Microfilaria will be present in CSF and usually in peripheral blood, with albuminuria, 
red blood cells and leukocytes in urine (Lukiana et al., 1996).  
7. Treatment of loiasis encephalopathy  
Treatment of L. loa encephalitis is based on nursing, nutritional support and re-hydration. 
According to Serious Adverse events (SEA) Experts in Loa loa endemic areas (Scientific 
working Group on SAE, 2003) Corticosteroids and antihistamines should be avoided. The 
reasons  for avoidance of corticosteroids are the lack of evidence of efficacy for this 
condition and potential harmful effect; while the antihistaminic treatment should be avoid 
because of the lack of efficacy and they sedate patient with a neurologic condition, 
interfering with diagnosis and neurologic assessment. The protocol suggested here is based 
on that described by Gardon et al., 1999. It is based on vital monitoring (pulse, arterial 
pressure, temperature, consciousness (Glasgow score), hydration, complete neurological 
and clinical examination every hour then every three hours. When the patient is dehydrated 
and systolic pressure is below 9 cmHg: perfuse 500 ml of Ringer lactate solution over 30 
min; if no improvement, continue to perfuse until systolic pressure reaches 10 cmHg and 
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diuresis 1 ml/kg/hour. Perfuse 2000 ml of 5% glucose (including 6 g of NaCl, 3-4 g of KCl, 2 
g of calcium) or mixt sera (with 4 g of KCl and 2 g of calcium) for 24 hours for an adult 
weighing 60 kg, or 500 ml every 6 hours (28 drops/minute). If dehydration persists, perfuse 
1000 ml of these solutions over 8 hours, depending on clinical status. In case of fever, add 1 
ml of solution per kilogram for each degree above 37°C. In case of coma, the treatment aim 
is to avoid bedsores, bronchial accumulation and intercurrent disorders, by mobilizing the 
patient every three hours and massages to prevent complications of decubitus; urinary 
probing, mouth care with sodium bicarbonate solution, and eye care with 9% NaCl. Pose of 
orpharyngeal canicle. If the Glasgow score is less than 10/15, transfer to a specialized 
intensive care unit. If recovery is slow, use gastric gavage with milk, soja…. Complementary 
examinations are necessary to rule out any other causes of coma (meningitis, hypo- or 
hyperglycemia, cerebral malaria, etc.), including thick blood smear (to search for Loa loa and 
malaria); glycemia, glycosuria, proteinuria and lumbar puncture (the liquid should be clear, 
but Loa loa microfilaria should be present between days 3 and 7 in Loa loa encephalitis). 
Removal of eye worm has been reported to cure spontaneous encephalitis (Kenney and 
Hewitt, 1950). 
8. The mechanism of encephalopathy and risk factors in loiasis: 
A high density of microfilaria (> 30000 mf/ml) seems to be the most plausible risk factor for 
Loa loa encephalopathy (Figure. 7). In addition, the genetic heterogeneity of this parasite 
could explain th e higher prevalence of encephalopathy in certain regions. However, 
parasites isolated in parts of Cameroon with a high prevalence of encephalopathy were not 
found to differ genetically from those found in other regions of Africa (Gabon and Nigeria) 
(Higazi et al., 2004). It has also been suggested that hybridization between simian and 
human strains of Loa loa may be a cofactor for encephalopathy, but this remains to be 
demonstrated. Although it is possible to cross human and simian strains of Loa loa, animal 
strains do not develop in humans, as demonstrated by implantation of simian adult 
parasites or injection of infective larvae (L3) in human volunteers (Duke, 2004; Nutman et 
al., 1991). Moreover, vectors of simian strains of C. langi and C. centurionis do not bite 
humans and tend to be active after dark. In contrast, human strains of Loa loa can be 
transmitted to non human primates, and hybrids of human and simian strains can be 
produced experimentally. However, the two sets of strains normally develop in different 
host-parasite systems (Fain, 1988), and such hybrids are unlikely to occur in natural 
conditions. A genetic predisposition to developing microfilaremia (Garcia et al., 1999) could 
also favor the onset of encephalitis in some cases. Coinfection by Loa loa and other parasites 
such as Plasmodium (Hartgers et al., 2006; Kamgno et al., 2008) bacteria (Bonnet et al., 1943; 
Cattan et al., 1960) and viruses (Cauchie et al., 1965), might cause lesions through which 
microfilaria could enter the nervous system and brain. However, it has been reported that 
treatment of such coinfections has little impact on the outcome of encephalitis (Kamgno et 
al., 2008). Finally, alcohol consumption has also been forwarded as a possible risk factor 
(scientific working group,2003).  
The pathophysiologic mechanisms underlying encephalitis in patients with loaisis may 
involve massive microfilarial death, leading to vascular embolism and inflammation. 
Interactions with drugs and other substances (alcohol, drugs, dietary components, etc.) may 
also play a role, through competition for biological carrier molecules. Glycoprotein P, a 
component of the blood-brain barrier, plays a role in drug entry to the brain. Substance P 
deficiency could lead to a rise in drug concentrations in the brain, resulting in severe 
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neurotoxicity. This deficiency could be caused by genetic polymorphism, deficient 
glycoprotein P production, or glycoprotein P inhibition. Indeed, severe neurological adverse 
effects of ivermectin are observed in CF-I mice, that are deficient in MDRIA glycoprotein P 
(Kwei et al., 1999). Several drug carrier molecules such as MDR, MRP, OATP and 
glycoprotein P have been detected on the apical and basolateral membranes of epithelial 
cells in cerebral capillary membranes (Cordon Cardo et al., 1989; Huai-Yun et al., 1998; 
Kusuhara et al., 1998; Gao et al., 1999). Glycoprotein P is the most widely studied of these 
molecules. The risk of encephalitis could also be influenced by genetic factors. Indeed, dogs 
homozygous for a 4-bp deletion of the MDR1 gene (resulting in premature termination of 
glycoprotein P synthesis) are highly sensitive to ivermectin (Mealy et al., 2001). In addition, 
CFI mice exhibiting low glycoprotein P production are more sensitive to ivermectin 
neurotoxicity than their wild-type counterparts (Umbenhauer et al., 1997). In addition to the 
neurotoxicity of ivermectin accumulating in the brain, through a deficiency in glycoprotein P 
or other carriers, neurotoxicity may result from interactions between drugs competing for the 
same carrier binding site. Other glycoprotein P substrates may compete with ivermectin, 
leading to a reduction in ivermectin efflux from the brain. This has been demonstrated in mice 
treated with both ivermectin and cyclosporine (Marques-Santos et al., 1999). It is important to 
note that ivermectin and DEC both lead to progressive neurological complications in patients 
with high microfilaremia and also ocular lesions (retinal or subconjunctival hemorrhage) 
linked to microemboli created by the parasite. It therefore appears that the etiology of Loa loa-
associated encephalitis associated with these two drugs is linked to clumping of dead 
microfilaria in vessels, leading to emboli and local vascular inflammation.  
 
 
 
 
Fig. 7. Two views of Loa loa microfilariae in blood of an hypermicrofilaremic individual 
It seems that the adult worm and microfilaria are both risk factors for spontaneous 
encephalitis. Adult worms have been implicated in the neuropsychological complications of 
loaisis in two European patients (Kenny & Hewitt, 1950). In both cases, extraction of the 
adult worm led to a clinical improvement and to a decline in eosinophilia from 56-50% to 
3%. Location of adult worms in the subarachidonic space at the base of the brain has also 
been implicated in neuropsychological complications (Bertrand-Fontaine et al., 1948). The 
abundance of microfilaria is an important risk factor, because of their mobility in small 
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vessels and capillaries and outside the circulatory apparatus. How exactly microfilaria cross 
the blood-brain barrier remains to be determined. As stated above, coinfection by other 
pathogens (such as Plasmodium) could weaken this barrier, leading to vascular lesions that 
allow microfilaria to enter the brain. Head trauma could have a similar effect. In well-
documented cases of encephalitis (Bogaert et al., 1955), it has been shown that microfilaria 
cross the vascular barrier and penetrate into deep tissues, where focal necrosis occurs 
around dead parasites. These foci are surrounded by inflammation and fibrosis, and giant 
multinucleated cells arise in the spleen, liver and brain. Aggregates of neurological 
 
 
 
 
Fig. 8. Potential immunological mechanisms for induction of Loa loa encephalitis           
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lymphocytes and histiocytes may form in cardiac tissue, with a few leukocytes close to 
microfilaria in extracranial organs. There is no evidence of phagocytosis. Alternatively,  
complications could be due to obstruction caused by microfilarial and to the toxicity of their 
metabolic products (Weil et al., 1926).  
The immune response could also play a role in encephalitis due to Loa loa, for example 
through the formation of circulating immune complexes that deposit in tissues and vessels. 
This could result in complement activation and influx of polymorphonuclear cells and 
basophils, followed by the release of vasoactive amines, causing retraction of endothelial 
cells and increased vascular permeability. Polymorphonuclear cells that fail to phagocytose 
deposits of immune complexes may degranulate, causing local tissue damage (Fig. 8A). The 
large amount of antigens associated with abundant microfilariosis may persistently 
stimulate an inefficient antibody response resembling type III hypersensitivity. Chronic 
lesions induced by such phenomena could lead to vessel destruction and encephalitis when 
they occur in the brain, or nephropathies when the kidneys are affected. Cardiac and renal 
involvement have both been described in loaisis. Alternatively, T lymphocytes sensitized by 
Loa loa antigens (Fig. 8B) could release cytokines, thus attracting activated macrophages. With 
the persistence of Loa loa antigens, activated macrophages could trigger chronic 
granulomatous reactions resembling type IV hypersensitivity. Such responses are observed in 
chronic infections such as schistosomiasis (Brian et al., 1983). Granulomas have been observed 
in the brain of a person infected by Loa loa. These observations suggest that type III and IV 
hypersensitivity reactions could be involved in the development of Loa loa encephalopathy. 
Finally, it is conceivable that spontaneous encephalitis is the end result of a long process 
involving deposits of immune complexes in several deep organs, the most sensitive being the 
brain and kidneys. Cofactors (drugs, coinfection, etc.) could accelerate this process. 
9. Ongoing and future directions 
Administration of filaricidal drugs in massively infected patients often results in encephalitis, 
in the absence of any other known cause. The mechanism underlying encephalitis in this 
setting is unclear. Microfilaria have been found in parasite-infected animal brains (Hashimoto, 
1939, quoted byJanssens,1952), including those coinfected by trypanosomes (Peruzzi, 1928). 
Consequently, the presence of Loa loa microfilaria in the brain cannot alone explain the onset of 
encephalitis. The heterogeneous nature of the associated clinical manifestations poses 
problems for prevention and timely patient management. Studies based on an experimental 
model, such as non human primates infected by human isolates, could help to identify 
predictive markers of Loa loa encephalitis and specific clinical complications (Orihel & 
Ebrehard 1985; Duke, 1960). Indeed, clinical expression of this filariosis is similar in humans 
and non human primates (Pinder et al., 1994), and hypermicrofilaremia can be reproduced in 
non human primates. Despite the existence of potent microfilaricidal drugs (DEC and 
ivermectin), new macrofilaricides or compounds capable of inducing a gradual decline in 
microfilaria without triggering encephalitis are needed. Most cases of encephalitis have been 
reported in Cameroon during mass treatment with ivermectin, but similar cases may go 
unreported in other endemic regions, especially if they occur in rural settings without 
adequate medical facilities. Specific studies are needed to evaluate the prevalence and 
characteristics of Loa loa encephalopathy in endemic areas. Studies of polymorphisms of 
human drug carrier molecules and proinflammatory cytokine synthesis are also necessary. As 
all current treatments, including albendazole (Blum et al., 2001), can induce encephalitis in 
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highly microfilaremic patients, the antifilarial activity of African traditional herbal remedies 
may be of interest. Most of these plants are well accepted and tolerated, and preliminary 
cytotoxicity results are encouraging (Mengome et al., 2010). There is currently no evidence of 
the existence of a symbiont in Loa loa (McGarry et al., 2003; Buttner et al., 2003), that might 
warrant concurrent antibiotic therapy for patients with loasis. Because Loa loa infection often 
goes undiagnosed, cases of encephalitis in Loa loa endemic areas may be attributed to viruses, 
bacteria or other parasites. This underdiagnosis is due partly to the lack of a simple, specific 
and rapid diagnostic test available at points of treatment for use by non specialists. Some 
candidate antigens have been identified and produced (Azzibrouck et al., 2010). Although 
spontaneous encephalitis may be caused by the adult worm, life-threatening forms are 
generally due to massive death of microfilaria. However, in endemic areas, about one-third of 
infected persons are microfilaremic and only 5% are strongly microfilaremic, the remainder 
being amicrofilaremic (Van Hoegaerden et al., 1986; Dupont et al., 1988). The fact that these 
latter persons live permanently in areas of continuous transmission without becoming 
microfilaremic points to the existence of a natural control mechanism. Further studies of these 
subjects could help to find ways of clearing microfilaria without triggering encephalitis. 
Noteworthy immunological differences have been found between microfilaremic and 
amicrofilaremic subjects. The latter patients exhibit a stronger immune response against Loa loa 
antigens, both qualitatively and quantitatively (Pinder et al., 1988; Pinder et al., 1992; Egwang 
et al., 1988a; Egwang et al., 1988b;Egwang et al.,1989; Akue et al., 1997; Akue et al., 1998; Baize 
et al.,1997; Akue & Devaney, 2002). Finally, more work is needed to determine the role of 
immune complex deposition in the onset of encephalitis in patients with loaisis. 
 
 
Fig. 9. Loa loa adult worm 
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10. Conclusion 
The risk of Loa loa encephalitis must be taken in to account when managing patients in and 
from endemic areas. This severe form can occur spontaneously or be triggered by antifilarial 
treatment in highly microfilaremic patients. The underlying mechanism appears to include 
embolism following massive death of microfilaria, genetic polymorphism of biological drug 
carriers, and immunological processes. More work is needed to develop a diagnostic test, as 
well as new drugs and possibly a vaccine. Further characterization of Loa loa encephalitis in 
endemic regions and in animal models is needed to understand the mechanisms underlying 
the onset and outcome of encephalitis in patients with loaisis. 
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